FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer… Grant US-11447553-B2 United States of America 20 Sep 2022
Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6… Grant US-11091555-B2 United States of America 17 Aug 2021
ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT Application WO-2018213304-A1 World Intellectual Property Organisation (WIPO) 22 Nov 2018